Alpha-Interferon in Angioimmunoblastic Lymphadenopathy
Authors: Jean-François Rossi, Nathalie Fegueux, Brigitte Calvet, Wandrille Godefroy
Journal: Annals of Internal Medicine (1988)

Letters and Corrections15 September 1988Alpha-Interferon in Angioimmunoblastic LymphadenopathyJean-François Rossi, MD, Nathalie Fegueux, MD, Brigitte Calvet, MD, Wandrille Godefroy, MDJean-François Rossi, MDSearch for more papers by this author, Nathalie Fegueux, MDSearch for more papers by this author, Brigitte Calvet, MDSearch for more papers by this author, Wandrille Godefroy, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-109-6-512 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor:We read with interest the article on angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) (1). This disease is characterized by a clonal expansion of both B and T lymphocytes with expression of a particular histologic pattern. Treatment usually consists of corticosteroids or alkylating agents, resulting in a poor prognosis. Little is known about the effect of alpha-interferon in such a disease. Only one patient has been successfully treated with alpha-interferon (2). Alpha-interferon has been shown to be an effective treatment in some T-cell lymphopathies, such as epidermotropic T-cell lymphomas (3). We report the case of a patient with AILD...References1. SteinbergSeldinJaffe AME. Angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med. 1988;108:575-84. LinkGoogle Scholar2. FeremansKhodadadi WE. Alpha-interferon therapy in refractory angio-immunoblastic lymphadenopathy. Eur J Haematol. 1987;37:91. Google Scholar3. RothFoon MK. Alpha-interferon in the treatment of hematologic malignancies. Am J Med. 1986;81:871-82. CrossrefMedlineGoogle Scholar4. LehnSigauxGrausz PFD. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia. Blood. 1986;68:967-70. CrossrefMedlineGoogle Scholar5. KlinmanSteinbergMushinski DAJ. Effect of cyclophosphamide therapy on oncogene expression in angioimmunoblastic lymphadenopathy. Lancet. 1986;2:1055-8. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Jean-François Rossi, MD; Nathalie Fegueux, MD; Brigitte Calvet, MD; Wandrille Godefroy, MDAffiliations: Produits Roche 52, 92521 Neuilly-S/Seine France PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDefining Essential Features of Myalgic Encephalomyelitis and Chronic Fatigue SyndromeCastleman's Disease: From Basic Mechanisms to Molecular TherapeuticsChronic Fatigue Syndrome in Male Gulf War Veterans and CiviliansChronic fatigue syndrome, exercise, cortisol and lymphadenopathySubclassifying Chronic Fatigue Syndrome through Exercise TestingFibromyalgia, fatigue, and headache disordersPhysiological responses to incremental exercise in patients with chronic fatigue syndromeChronic Fatigue SyndromeDevelopment of the 1994 Chronic Fatigue Syndrome Case Definition and Clinical Evaluation GuidelinesNecrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemiaLong-term complete remission after interferon treatment in a case of multicentric castelman's diseaseChronic fatigue syndrome: A new challenge for health care professionalsThe Chronic Fatigue SyndromeHigh titers of anti-epstein-barr virus DNA polymerase are found in patients with severe fatiguing illnessThe Pathophysiology of Chronic Fatigue Syndrome: Confirmations, Contradictions, and ConjecturesSuccessful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin ATreatment of Primary and Relapsed Angioimmunoblastic-Type T-Cell Lymphoma with Recombinant Human Interferon-αImproved response to chemotherapy after interferon alpha-2b in angioimmunoblastic lymphadenopathy (AILD)Les interféronsLYMPHOGRANULOMATOSIS X: COMPLETE REMISSION BY LOW DOSE INTERFERON-ALPHA 15 September 1988Volume 109, Issue 6Page: 512-513KeywordsLymphocytesLymphoma ePublished: 1 December 2008 Issue Published: 15 September 1988 PDF downloadLoading ...